Researchers have successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein — providing a promising path for new COVID-19 therapeutics.
Researchers have successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein — providing a promising path for new COVID-19 therapeutics.